SONATA THERAPEUTICS

Pharmaceutical agents and products, namely, pharmaceutical agents for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules, namely, pharmaceutical preparations for the treatment of cancer; pharmaceutical compositions in the nature of chemical and biological small molecules, namely, pharmaceutical preparations for the treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation, namely, pharmaceutical preparations for the treatment of cancer

Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others, namely, development of pharmaceutical preparations and medicines; technical scientific research consultation and product development for others in the field of biotechnology and development of pharmaceuticals; scientific research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development of pharmaceutical data in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals